BioVersys AG (SWX:BIOV)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
34.00
+0.20 (0.59%)
At close: Jul 31, 2025, 5:20 PM CET

Exscientia Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Other Revenue
1.211.14
1.211.14
Revenue Growth (YoY)
6.50%-
Gross Profit
1.211.14
Selling, General & Admin
74.02
Research & Development
12.9514.83
Operating Expenses
19.9418.84
Operating Income
-18.73-17.7
Interest Expense
-1.03-0.7
Interest & Investment Income
0.50.48
Currency Exchange Gain (Loss)
0.13-0.16
Other Non Operating Income (Expenses)
0.42-0.22
Pretax Income
-18.72-18.3
Net Income
-18.72-18.3
Net Income to Common
-18.72-18.3
Shares Outstanding (Basic)
33
Shares Outstanding (Diluted)
33
Shares Change (YoY)
11.60%-
EPS (Basic)
-5.62-6.13
EPS (Diluted)
-5.62-6.13
Free Cash Flow
-15.61-11.7
Free Cash Flow Per Share
-4.68-3.92
Gross Margin
100.00%100.00%
Operating Margin
-1544.11%-1554.17%
Profit Margin
-1543.20%-1606.76%
Free Cash Flow Margin
-1287.06%-1027.57%
EBITDA
-18.67-17.65
D&A For EBITDA
0.060.06
EBIT
-18.73-17.7
Revenue as Reported
1.211.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.